Publicacións en colaboración con investigadores/as de Research Institute for Tropical Medicine (7)

2022

  1. Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

    Journal of Infectious Diseases, Vol. 225, Núm. 9, pp. 1521-1532

  2. Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. 107-117

2020

  1. Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

    The Lancet, Vol. 395, Núm. 10234, pp. 1423-1433

  2. Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial

    The Pediatric infectious disease journal, Vol. 39, Núm. 1, pp. e1-e10

2019

  1. Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine

    The Pediatric infectious disease journal, Vol. 38, Núm. 8, pp. 866-872

  2. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents

    New England Journal of Medicine, Vol. 381, Núm. 21, pp. 2009-2019

2018

  1. Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

    The Lancet Child and Adolescent Health, Vol. 2, Núm. 5, pp. 338-349